Who are we?

The New York metropolitan area is one of the major scientific hubs in the United States. This tri-state area is home to an impressive array of world-class academic and research institutions, including world-renowned universities and many public and private research laboratories. The New York metropolitan area is the second largest area in the United States in terms of public research funding. On the other hand, this region is at the crossroads of finance, legal and international business, facilitating entrepreneurship in all aspects of science and technology. People from all over the globe come to this region as graduate students, postdocs, research scientists and entrepreneurs, constituting one of the most vibrant and dynamic scientific communities in the world; and Spanish scientists contribute greatly to this community. This reality made possible the development of a platform to ease interactions between researchers, science professionals, entrepreneurs and Spanish institutions located here. As such, ECUSA-NY vow to promote these types of meetings.

Keep growing ans sharing experiences with us!

What do we do?

We organize events and promote networking between ECUSA members. We look forward to seeing you at all of our events, which we will inform you about on this New York Chapter web-page and through ECUSA’s social media channels.

Chapter Board


Ylenia Cendón Florez


Ylenia obtained her Ph.D. in Molecular Biosciences from the Autonomous University of Madrid, working on inherited mutations in Prostate Cancer at the Spanish National Cancer Research Center. Nowadays she is a Postdoctoral Fellow at Memorial Sloan-Kettering Cancer Center in New York. Her work is focused on understanding how chromosomal rearrangements drive tumorigenesis and contribute to drug resistance. Apart from science, she is also passionate about meeting people and new places, music, and art.


Lucia Regales


Lucia Regales is a senior scientific clinical director at Curis, where she leads the scientific development program for two new immunotherapies and specializes in cancer precision medicine. Graduated in biochemistry from the University of Oviedo, she completed her doctoral thesis in Molecular Biology at the CSIC National Center for Biotechnology and her postdoctoral research at Memorial Sloan Kettering in New York, based on the study and identification of new genomic mutations of resistance to cancer (EGFR, K-RAS genes) and development of new target therapies to combat them. These studies led to the performance of several phase I-III clinical trials in lung cancer patients. She subsequently worked in big pharma, as a medical liaison at Elli Lilly, and held various regional and global positions as scientific director at Merck, being part of the development of one of the first anti-PD-L1 immunocheckpoint inhibitors and biomarkers for this type of immunotherapies.

Juan Francisco Rodríguez


Juan holds a Ph.D. in Molecular Biomedicine from the University of Bonn, Germany, and is deeply passionate about Immunology. Currently, Postdoctoral Researcher in the Pediatrics Department at Weill Cornell Medicine. Presently, he serves as a Postdoctoral Associate in the Pediatrics Department at Weill Cornell Medicine. His research is dedicated to unraveling the intricate molecular patterns underlying autoimmune diseases, with a specific focus on pediatric systemic lupus erythematosus. Juan’s professional mission revolves around identifying innovative molecular targets that can pave the way for the development of personalized therapies, ultimately aiming to enhance treatment strategies for individuals grappling with inflammatory diseases.

Imanol Miqueleiz


Imanol Miqueleiz is an environmental biologist, specialized in freshwater conservation. He obtained his Ph.D. from the University of Navarra in 2020 on a study about the knowledge of the conservation status of freshwater fishes. . In 2021, he worked for the Iberian Society of Ichthyology evaluating the conservation status of several endangered endemic freshwater fish species, proposing its protection under Spanish legislation. In 2022, he started postdoctoral research at Cornell University, where he studies the optimization of conservation opportunities in freshwater ecosystems.


Adrián Vega

Advisory – NY

Adrián Vega holds a degree in Pharmacy from the Universidad Complutense of Madrid. He earned his doctorate in Molecular Biosciences from Universidad Autónoma de Madrid in 2021 working at CNB-CSIC. During his PhD work he studied the innate immune system in the context of bacterial infections. He is currently a postdoctoral researcher at Weill Cornell Medicine (New York, USA) where he uses CRISPR base editing technologies to better understand the immune microenvironment in the context of tumor development.


Alba Boix Amorós

CD Advisory – NY

twitter icon

She received her Ph.D. in Biotechnology from the Polytechnic University of Valencia (Spain), where she studied the human milk microbiome in health and during lactational mastitis. She is currently a postdoctoral researcher at the Icahn School of Medicine at Mount Sinai Hospital in New York, where her work is focused on the study of the human microbiome in different settings, including the maternal transfer of bacteria to the infant at delivery and the protective role of a healthy microbiome against disease.


Irene González-Domínguez


Irene Gonzalez-Dominguez works in the department of Microbiology at the Icahn School of Medicine at Mount Sinai, and her research is focused on vaccine development against infection diseases. For over 10 years she has been working on the development of next generation viral-based vaccine candidates. Her doctoral studies at the Autonomous University of Barcelona involved the characterization and development of a purification process for third-generation virus-like particles (VLPs) as a novel vaccine platform against HIV-1. Currently she is involved in the generation of a low-cost vaccine platform against SARS-CoV-2 infection for low- and middle-income countries (LMIC) using an avirulent Newcastle Disease virus (NDV) as a viral vector vaccine known as NDV-HXP-S and the development of a universal influenza vaccine based on mosaic hemagglutinin constructs using recombinant influenza B viruses.


Anna Adam Artigues

MECUSA Advisory – NY

Anna is a postdoctoral researcher at Cancer Dormancy and Tumor Microenvironment Institute at Albert Einstein College of Medicine in New York, where she studies how cancer cells can remain dormant in secondary organs for long periods of time. Her objective is to prevent these cells from reawakening and to find therapeutic strategies to eliminate them. She carried out her PhD thesis at the INCLIVA Health Research Institute associated with the Clinical Hospital of Valencia and the University of Valencia, where she studied the mechanisms of resistance to therapy in breast cancer. She has a degree in biotechnology from the Polytechnic University of Valencia and has made several internships abroad (Mount Sinai in New York and Cancer Research Center UK in Liverpool). During her career she has published in hig-impact journals and received several awards and fellowships. Anna has been involved in several activities related to science dissemination and, in particular, to the role of women in science, such as Conócelas (ASEICA). n 2022, she joined MECUSA to continue promoting gender equality in science.


Ana Centelles

ECUSA Forward Advisory – NY

Ana Centelles works as the Business Development Manager at Quibim, a Spanish medtech company. In addition to driving the creation of new partnerships with pharmaceutical companies and CROs, she coordinates the reimbursement and market access strategy for the company’s products. With a degree in Microbiology from the Autonomous University of Barcelona, Ana was awarded the ICEX governmental scholarship, which she used to complete her MBA. During her time at the health department of the Trade Commission of Spain in Chicago, she supported the internationalization of Spanish companies in the sector towards the United States. Additionally, scientific outreach has always been a fundamental part of her career, and she has led a science podcast on the local radio in her hometown.


Elizabeth Leon Palmero

MECUSA Advisory – NY

Elizabeth is a biologist and currently a Marie Curie fellow at Princeton University, where she studies the microbial and chemical processes controlling the budget of the potent greenhouse gas nitrous oxide in the ocean. She developed her PhD work at the University of Granada studying greenhouse gas fluxes in reservoirs In 2022 she started her postdoctoral research on production and consumption of N2O in the Baltic Sea and in the Greenland Sea at the University of Southern Denmark. Elizabeth is also part of the Gender & Science AIL group and the Diversity and Inclusion Commission of the Iberian Society of Ecology.


Let’s talk

Email us to our ECUSA New York email: newyork@ecusa.es or fill out the

contact form below.